135 related articles for article (PubMed ID: 10789078)
1. [Use of interferon-alpha (IFN-alpha) in the treatment of keratoacanthoma].
Somlai B; Holló P
Hautarzt; 2000 Mar; 51(3):173-5. PubMed ID: 10789078
[TBL] [Abstract][Full Text] [Related]
2. Large keratoacanthomas in difficult locations treated with intralesional 5-fluorouracil.
Parker CM; Hanke CW
J Am Acad Dermatol; 1986 May; 14(5 Pt 1):770-7. PubMed ID: 3711381
[TBL] [Abstract][Full Text] [Related]
3. Intralesional interferon alfa-2b treatment of keratoacanthomas.
Oh CK; Son HS; Lee JB; Jang HS; Kwon KS
J Am Acad Dermatol; 2004 Nov; 51(5 Suppl):S177-80. PubMed ID: 15577764
[TBL] [Abstract][Full Text] [Related]
4. Large keratoacanthomas treated with intralesional interferon alfa-2a.
Grob JJ; Suzini F; Richard MA; Weiller M; Zarour H; Noe C; Munoz MH; Bonerandi JJ
J Am Acad Dermatol; 1993 Aug; 29(2 Pt 1):237-41. PubMed ID: 8335744
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of keratoacanthoma with intralesional methotrexate injections].
Richard MA; Gachon J; Choux R; Laurans R; Folchetti G; Grob JJ
Ann Dermatol Venereol; 2000 Dec; 127(12):1097. PubMed ID: 11173689
[No Abstract] [Full Text] [Related]
6. A case of multiple keratoacanthoma centrifugum marginatum.
Mangas C; Bielsa I; Ribera M; Fernández-Figueras MT; Ferrándiz C
Dermatol Surg; 2004 May; 30(5):803-6. PubMed ID: 15099330
[TBL] [Abstract][Full Text] [Related]
7. Giant keratoacanthoma-type low-grade squamous cell carcinoma of the upper lip: Response to intralesional interferon alpha-2B.
Anadolu R; Akay BN; Bodamyali P; Akyol A
J Dermatolog Treat; 2011 Aug; 22(4):239-40. PubMed ID: 20666675
[No Abstract] [Full Text] [Related]
8. [Keratoacanthoma centrifugum marginatum].
Chaffai M; Houman MH; Haouet S; Ben Osman A
Ann Dermatol Venereol; 1994; 121(10):731-3. PubMed ID: 7793766
[TBL] [Abstract][Full Text] [Related]
9. Intralesional therapy for the treatment of keratoacanthoma.
Kiss N; Avci P; Bánvölgyi A; Lőrincz K; Szakonyi J; Gyöngyösi N; Fésűs L; Lee G; Wikonkál N
Dermatol Ther; 2019 May; 32(3):e12872. PubMed ID: 30866135
[TBL] [Abstract][Full Text] [Related]
10. [Intralesional methotrexate injection: an effective time and cost saving therapy alternative in keratoacanthomas that are difficult to treat surgically].
Remling R; Mempel M; Schnopp N; Abeck D; Ring J
Hautarzt; 2000 Aug; 51(8):612-4. PubMed ID: 10997318
[TBL] [Abstract][Full Text] [Related]
11. [Use of Ufudix ointment for the treatment of keratoacanthoma. I. Clinical evaluation of the results].
Starzycki Z
Przegl Dermatol; 1980; 67(4):469-74. PubMed ID: 7001547
[No Abstract] [Full Text] [Related]
12. Keratoacanthoma centrifugum marginatum: a diagnostic and therapeutic challenge.
Divers AK; Correale D; Lee JB
Cutis; 2004 Apr; 73(4):257-62. PubMed ID: 15134326
[TBL] [Abstract][Full Text] [Related]
13. The role of etretinate (Tegison; Tigason) in the management of keratoacanthoma.
Cristofolini M; Piscioli F; Zumiani G; Scappini P
J Am Acad Dermatol; 1985 Apr; 12(4):633-8. PubMed ID: 3989024
[TBL] [Abstract][Full Text] [Related]
14. Treatment of keratoacanthomas with intralesional methotrexate.
Melton JL; Nelson BR; Stough DB; Brown MD; Swanson NA; Johnson TM
J Am Acad Dermatol; 1991 Dec; 25(6 Pt 1):1017-23. PubMed ID: 1810980
[TBL] [Abstract][Full Text] [Related]
15. Successful treatment of keratoacanthoma centrifugum marginatum with local application of imiquimod cream.
Aroni K; Mastoraki A; Agrogiannis G; Ioannidis E; Patsouris E
Int J Dermatol; 2007 Dec; 46(12):1321-2. PubMed ID: 18173541
[No Abstract] [Full Text] [Related]
16. Intralesional interferon-α for conjunctival mucosa-associated lymphoid tissue lymphoma: long-term results.
Blasi MA; Tiberti AC; Valente P; Laguardia M; Sammarco MG; Balestrazzi A; Larocca LM; Balestrazzi E
Ophthalmology; 2012 Mar; 119(3):494-500. PubMed ID: 22226154
[TBL] [Abstract][Full Text] [Related]
17. Topical and intralesional treatment of nonmelanoma skin cancer: efficacy and cost comparisons.
Chitwood K; Etzkorn J; Cohen G
Dermatol Surg; 2013 Sep; 39(9):1306-16. PubMed ID: 23915332
[TBL] [Abstract][Full Text] [Related]
18. Topical treatment with imiquimod may induce regression of facial keratoacanthoma.
Dendorfer M; Oppel T; Wollenberg A; Prinz JC
Eur J Dermatol; 2003; 13(1):80-2. PubMed ID: 12609789
[TBL] [Abstract][Full Text] [Related]
19. The use of podophyllin in the treatment of keratoacanthoma.
Cipollaro VA
Int J Dermatol; 1983 Sep; 22(7):436-40. PubMed ID: 6629612
[TBL] [Abstract][Full Text] [Related]
20. Intralesional methotrexate in keratoacanthoma of the nose.
Hurst LN; Gan BS
Br J Plast Surg; 1995 Jun; 48(4):243-6. PubMed ID: 7640859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
